A systematic review reports that monoclonal antibodies and JAK inhibitors can be effective in the treatment and clearance of ...
Quoin Pharmaceuticals Ltd. has announced the filing of U.S. and International patent applications for new topical formulations of rapamycin aimed at treating rare diseases such as microcystic ...
Steven Daniel Daveluy, MD, FAAD, discussed how artificial intelligence (AI) can leverage extensive patient data and guide dermatologists to improve early diagnosis and treatment of rare dermatological ...
Researchers from Nagoya University Graduate School of Medicine in Japan have successfully treated the skin diseases epidermolytic ichthyosis (EI) and ichthyosis with confetti (IWC) by transplanting ...
Quoin Pharmaceuticals Ltd. has filed a U.S. patent application for new topical formulations aimed at treating several skin diseases, specifically Netherton Syndrome (NS) and Peeling Skin Syndrome. The ...
Q: What is epidermolysis bullosa? A: Epidermolysis bullosa is a group of rare skin disorders that cause fragile, blistering skin. There are four major subtypes of EB and more than 30 different ...
For years, doctors couldn’t explain why Cydney Carter was breaking out with painful “boils” on her skin. Then, she received a diagnosis that changed her life. Share on Pinterest After years of living ...
Researchers from Nagoya University Graduate School of Medicine in Japan have successfully treated the skin diseases epidermolytic ichthyosis (EI) and ichthyosis with confetti (IWC) by transplanting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback